MICHELLE CENERIZIO: Open Payments
NPI 1629410204 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 10 payments from 7 companies in 2025. Trend: 2023 $27 · 2024 $56 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $171 |
| Axsome Therapeutics, Inc. | 1 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: OTEZLA, Auvelity, CAPLYTA, REXULTI, PURIFIED CORTROPHIN GEL, AUSTEDO XR, INGREZZA.
Industry payments across VA — which companies pay providers there.
